BioMarin Pharmaceutical Inc. buy Wolfe Research
Start price
15.11.24
/
50%
€60.78
Target price
15.11.25
€89.95
Performance (%)
-22.26%
End price
16.11.25
€47.25
Summary
This prediction ended on 16.11.25 with a price of €47.25. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -22.26%. Wolfe_Research has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.031% | -3.031% | -10.521% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% |
Comments by Wolfe_Research for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $95.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten
Current prediction by Wolfe_Research for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.93
15.07.25
15.07.25
€81.42
15.07.26
15.07.26
-5.81%
14.04.26
14.04.26
Stopped prediction by Wolfe_Research for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.46
16.03.26
16.03.26
-
16.03.27
16.03.27
-6.80%
14.04.26
14.04.26